Cargando…

Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder

Depression is a significant cause of morbidity and mortality globally. Although various pharmacologic options exist for depression, treatments are limited by delayed or incomplete therapeutic response, low rates of remission, and adverse effects necessitating effective, fast-acting, and better toler...

Descripción completa

Detalles Bibliográficos
Autores principales:	McCarthy, Brian, Bunn, Hannah, Santalucia, Morgan, Wilmouth, Charlotte, Muzyk, Andrew, Smith, Colin M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591164/ https://www.ncbi.nlm.nih.gov/pubmed/37859435 http://dx.doi.org/10.9758/cpn.23.1081

Ejemplares similares

Rapid-acting oral drug (Auvelity) for major depressive disorder
por: Khabir, Yumna, et al.
Publicado: (2022)

Sublingual Dexmedetomidine for the Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorder
por: Smith, Colin M., et al.
Publicado: (2023)

Improvement of depressive symptoms, after a suicide attempt, with dextromethorphan/bupropion combination treatment in a patient with treatment‐resistant depression and psychiatric comorbidities
por: Pedraz‐Petrozzi, Bruno, et al.
Publicado: (2023)

Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy Subjects
por: Yamazaki, Takao, et al.
Publicado: (2016)

Comparing the Effects of Bupropion and Escitalopram on Excessive Internet Game Play in Patients with Major Depressive Disorder
por: Nam, Beomwoo, et al.
Publicado: (2017)

Resolution of Pregabalin and Mirtazapine Associated Restless Legs Syndrome by Bupropion in a Patient with Major Depressive Disorder
por: Park, Young-Min, et al.
Publicado: (2009)

Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder: Results of a Pilot Study
por: McElroy, Susan L., et al.
Publicado: (2013)

Dextromethorphan improved cyclosporine-induced depression in mice model of despair
por: Mesripour, Azadeh, et al.
Publicado: (2020)

Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′-OH-bupropion in vitro
por: Sager, Jennifer E., et al.
Publicado: (2016)

Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized–controlled trials comparison with venlafaxine
por: Maneeton, Narong, et al.
Publicado: (2013)

Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review
por: Dahlberg, Sarah, et al.
Publicado: (2022)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Effectiveness and Safety of Bupropion in Children and Adolescents with Depressive Disorders: A Retrospective Chart Review
por: Kweon, Kukju, et al.
Publicado: (2019)

Comparison of the efficacy of venlafaxine and bupropion in the treatment of depressive episode in patients with bipolar II disorder
por: Fakhri, Ahmad, et al.
Publicado: (2023)

Effects of Dextromethorphan on Depressive-and Cognitive-Associated Behaviors: A Sexually Dimorphic Study
por: Ijomone, Omamuyovwi Meashack, et al.
Publicado: (2019)

Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study
por: Guerdjikova, Anna I., et al.
Publicado: (2017)

Hyponatremia Associated with Bupropion
por: Kim, Chang Seong, et al.
Publicado: (2011)

Signs & Symptoms of Dextromethorphan Exposure from YouTube
por: Chary, Michael, et al.
Publicado: (2014)

Evaluation of dextromethorphan with select antidepressant therapy for the treatment of depression in the acute care psychiatric setting
por: Nofziger, Jill L., et al.
Publicado: (2019)

Dextromethorphan Protect the Valproic Acid Induced Downregulation of Neutrophils in Patients with Bipolar Disorder
por: Lu, Ru-Band, et al.
Publicado: (2020)

Dextromethorphan Inhibits Activations and Functions in Dendritic Cells
por: Chen, Der-Yuan, et al.
Publicado: (2013)

Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
por: Khoury, Rita
Publicado: (2021)

Antipsychotic Drugs Efficacy in Dextromethorphan-Induced Psychosis
por: Zaremba, Malgorzata, et al.
Publicado: (2023)

Bilateral nephrolithiasis following ingestion of guaifenesin and dextromethorphan
por: Kim, Elizabeth, et al.
Publicado: (2023)

Two Cases of Dextromethorphan Overdose Reversed by Naloxone
por: Kumar, Dhruva, et al.
Publicado: (2023)

Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice
por: Stapleton, John, et al.
Publicado: (2013)

Bupropion Maintenance Treatment in Refractory Bipolar Depression: A Case Report
por: Dehning, Julia, et al.
Publicado: (2017)

Can bupropion unmask psychosis
por: Grover, Sandeep, et al.
Publicado: (2009)

Bupropion-Induced Erythema Multiforme
por: Evrensel, Alper, et al.
Publicado: (2015)

Tardive Dyskinesia Associated with Bupropion
por: Tuman, Taha Can, et al.
Publicado: (2017)

Bupropion-Induced Severe Leukocytosis
por: Jolly, Taranjeet S, et al.
Publicado: (2020)

Erythrodermic Psoriasis Exacerbated by Bupropion
por: Foss, Michael G, et al.
Publicado: (2021)

“Robo-Tripping”: Dextromethorphan Abuse and its Anesthetic Implications
por: Linn, Kelly A, et al.
Publicado: (2014)

Effects of dextromethorphan and oxycodone on treatment of neuropathic pain in mice
por: Yang, Pao-Pao, et al.
Publicado: (2015)

Mechanisms of the antiplatelet and analgesic effects of dextromethorphan and its metabolites
por: Su, Wen-Lin, et al.
Publicado: (2019)

Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia
por: Tampi, Rajesh R, et al.
Publicado: (2020)

Improvement in Sexual Functioning in Patients With Type 2 Diabetes and Depression Treated With Bupropion
por: Sayuk, Gregory S., et al.
Publicado: (2011)

The Accompanying Changes in Brain Structure of a Remitted Depression Patient with the Bupropion Treatment
por: Hou, Yi-Cheng, et al.
Publicado: (2015)

The efficacy and safety of bupropion sustained-release formulation for the treatment of major depressive disorder: a multi-center, randomized, double-blind, placebo-controlled study in Asian patients
por: Koshino, Yoshifumi, et al.
Publicado: (2013)

Bupropion hydrobromide propanol hemisolvate
por: Liu, Min, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_anb0semkk80tu64hh86q1sjgvu